You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Cubist agrees to acquire 2 drug makers

Lexington-based Cubist makes Cubicin.

istockphoto.com

Lexington-based Cubist makes Cubicin.

Continue reading below

Cubist Pharmaceuticals Inc., best-known for its antibiotic Cubicin, will pay up to $1.6 billion to acquire two other drug makers in a bid to increase its line of antibiotics. The deal to buy Optimer Pharmaceuticals and Trius Therapeutics adds an antibacterial drug to its product portfolio and puts several other antibiotics in its pipeline for approval. The deals are expected to ultimately generate between $600 million and $1 billion in annual revenue, Cubist CEO Michael Bonney said.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week